$84.95
27 in stock
Retatrutide Research Peptide 10 MG
Retatrutide research peptide, also known as LY3437943, is a synthetic peptide investigated for its triple-receptor agonist activity involving the GLP-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR). Retatrutide is also commonly referenced in research-product searches as Reta, R3TA, and GLP-3.
Retatrutide is of particular scientific interest because it combines activity across three distinct receptor pathways within a single peptide. Published laboratory research has examined its interactions with GLP-1R, GIPR, and GCGR and the molecular mechanisms involved in multi-receptor signaling.
This material is supplied in lyophilized form for controlled laboratory and analytical research applications.
Product Specifications
* Compound: Retatrutide
* Research Names: Reta, R3TA, GLP-3
* Development Code: LY3437943
* Quantity: 10 MG
* Form: Lyophilized research material
* Research Class: GLP-1R / GIPR / GCGR triple-receptor agonist
* Testing: Third-party tested
* Documentation: Batch-specific laboratory test results available
Third-Party Testing & COA
Quality and analytical verification are important when selecting research materials. This Retatrutide research peptide is supplied with third-party testing documentation for the applicable batch. Researchers can review the available laboratory test result for additional information regarding the material and reported purity.
Research Use Notice
This product is supplied strictly as a research material for laboratory and analytical research purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or other clinical applications.
Lab Test Result
Published Research: Retatrutide (LY3437943) Triple-Receptor Agonist Study